Tina Bhutani

Dec 11, 2024 | jamanetwork.com | Andrew Alexis |Amy J. McMichael |Tina Bhutani

Key PointsQuestion  Can innovative clinical trial design overcome barriers to recruiting and retaining participants with psoriasis and skin of color? Findings  This quality improvement study found that the VISIBLE trial achieved broad diversity among its approximately 200 participants through self-identification of race and ethnicity and inclusion of all skin types.

Oct 4, 2024 | mdedge.com | April Armstrong |Robert Bissonnette |Raj Chovatiya |Tina Bhutani

Psoriasis is a chronic inflammatory disease affecting approximately 8 million adults in the United States and 2% of the global population.1,2 Psoriasis causes pain, itching, and disfigurement and is associated with a physical, psychological, and economic burden that substantially affects health-related quality of life.3-5 Setting treatment goals and treating to target are evidence-based approaches that have been successfully applied to several chronic diseases to improve patient outcomes,...